Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro
Mammarenaviruses cause chronic infections in rodents, which are their predominant natural hosts. Human infection with some of these viruses causes high-consequence disease, posing significant issues in public health. Currently, no FDA-licensed mammarenavirus vaccines are available, and anti-mammaren...
Main Authors: | Yu-Jin Kim, Beatrice Cubitt, Yingyun Cai, Jens H. Kuhn, Daniel Vitt, Hella Kohlhof, Juan C. de la Torre |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/8/821 |
Similar Items
-
Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis
by: Fanxun Zeng, et al.
Published: (2021-03-01) -
Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia
by: Arthur Branstrom, et al.
Published: (2022-02-01) -
Cellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication
by: Haydar Witwit, et al.
Published: (2024-08-01) -
A novel and potent dihydroorotate dehydrogenase inhibitor suppresses the proliferation of colorectal cancer by inducing mitochondrial dysfunction and DNA damage
by: Xiaowei Yang, et al.
Published: (2022-06-01) -
Progress in Anti-Mammarenavirus Drug Development
by: Yu-Jin Kim, et al.
Published: (2021-06-01)